Talk:Azilsartan
Latest comment: 4 years ago by Doc James in topic Rename the page to Azilsartan medoxomil?
This is the talk page for discussing improvements to the Azilsartan article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||
|
Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Azilsartan.
|
Prodrug vs active ingredient edit
The article is for Azilsartan, but the structure shown is the prodrug Azilsartan medoxomil. I suggest that the image be changed to the active drug structure. -- The chemistds (talk) 13:59, 2 March 2011 (UTC)
- That might be right, but the article seems a bit off. The refs are very sketchy. There are lots of trials but few published results except for PMID 20379769. LeadSongDog come howl! 03:20, 6 April 2011 (UTC)
Rename the page to Azilsartan medoxomil? edit
The text of the page is mostly about the drug azilsartan medoxomil but many of the drugbox entries are for azilsartan. Should there be separate pages for Azilsartan and Azilsartan medoxomil? Should this page be renamed to Azilsartan medoxomil? Whywhenwhohow (talk) 17:22, 9 March 2020 (UTC)
Doc James (talk · contribs) What are your thoughts? Whywhenwhohow (talk) 04:52, 26 March 2020 (UTC)
- Remark: Not sure whether we have a policy on this (we do for salts: the article is called Diclofenac, not Diclofenac sodium), but the same question applies to candesartan cilexetil. --ἀνυπόδητος (talk) 08:48, 26 March 2020 (UTC)